tiprankstipranks
Trending News
More News >
Nutrien Ltd (TSE:NTR)
TSX:NTR
Advertisement

Nutrien (NTR) AI Stock Analysis

Compare
784 Followers

Top Page

TSE:NTR

Nutrien

(TSX:NTR)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
C$83.00
▲(6.93% Upside)
Nutrien's overall stock score reflects a balanced view of its financial stability, technical challenges, reasonable valuation, and positive earnings call sentiment. The company's strong cash flow and improved sales guidance are significant positives, while technical indicators suggest caution. The strategic focus on cost management and increased shareholder returns further supports the stock's potential.
Positive Factors
Revenue Growth
The significant increase in adjusted EBITDA indicates strong demand and effective operations, suggesting a positive trajectory for revenue growth.
Cash Flow Generation
Strong free cash flow growth enhances financial flexibility and supports strategic investments, dividends, and share repurchases.
Market Position
Anticipated record potash shipments highlight Nutrien's strong market position and ability to meet growing global demand, supporting long-term growth.
Negative Factors
Profitability Pressure
Compressed margins indicate challenges in maintaining profitability, which could affect long-term financial health if not addressed.
Operational Challenges
Operational disruptions in Trinidad could impact cash flow and profitability, highlighting risks in supply chain reliability.
Increased Leverage
Increased leverage may constrain financial flexibility and elevate risk, potentially impacting future investment and growth opportunities.

Nutrien (NTR) vs. iShares MSCI Canada ETF (EWC)

Nutrien Business Overview & Revenue Model

Company DescriptionNutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia. In addition, it provides services directly to growers through a network of farm centers in North America, South America, and Australia. The company was founded in 2017 and is headquartered in Saskatoon, Canada.
How the Company Makes MoneyNutrien generates revenue primarily through the sale of fertilizers and agricultural inputs, with significant contributions from both its Retail and Wholesale segments. The Wholesale segment focuses on producing and selling potash, nitrogen, and phosphate fertilizers to agricultural customers globally, while the Retail segment provides farmers with crop inputs, crop protection products, and agronomic services. Key revenue streams include sales of nutrient products, retail sales of seeds and crop protection chemicals, and the provision of agronomic advice and services. Nutrien also benefits from strategic partnerships with agricultural producers and cooperatives, enhancing its distribution capabilities and market reach. Additionally, fluctuations in commodity prices, particularly for potash and nitrogen, play a crucial role in the company's financial performance, driving revenues based on global supply and demand dynamics.

Nutrien Earnings Call Summary

Earnings Call Date:Nov 05, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Neutral
Nutrien delivered strong results with record fertilizer sales, improved reliability, and higher retail earnings, coupled with increased shareholder returns. However, challenges with the Trinidad operations and the strategic review of the Phosphate business present concerns. While positive market conditions support a favorable outlook, these issues indicate certain operational challenges.
Q3-2025 Updates
Positive Updates
Record Fertilizer Sales Volumes
Nutrien delivered record upstream fertilizer sales volumes, with an increase of approximately 750,000 tonnes compared to the same period last year. Potash sales volumes reached a new high in the first 9 months of 2025.
Nitrogen Operations Improvement
The company achieved a 94% ammonia utilization rate through the first 9 months, up 7 percentage points from the previous year, indicating significant progress on reliability initiatives across the Nitrogen business.
Retail Segment Growth
The Downstream Retail segment delivered 5% higher adjusted EBITDA in the first 9 months by reducing expenses and growing proprietary product gross margin. Nutrien is on track to achieve a $200 million cost reduction target one year ahead of schedule.
Increased Shareholder Returns
Nutrien allocated $1.2 billion to dividends and share repurchases in the first 9 months, representing a 42% increase from the prior year.
Positive Market Outlook
Nutrien expects record global potash shipments for 2025 between 73 million and 75 million tonnes, with strong demand anticipated to continue in 2026.
Negative Updates
Trinidad Operations Shutdown
A controlled shutdown of the Trinidad Nitrogen operations occurred due to port access uncertainty and unreliable gas supply, impacting projected contributions to consolidated free cash flow.
Phosphate Business Strategic Review
Nutrien initiated a strategic review of its Phosphate business due to its limited contribution to EBITDA and ongoing challenges.
Increased Costs in Potash Production
Year-to-date controllable cash costs of potash product manufactured were slightly higher than the prior year due to lower planned production and increased turnaround costs.
Company Guidance
During Nutrien's 2025 Third Quarter Earnings Call, the company provided several key metrics and updates. Nutrien reported a 42% year-over-year increase in adjusted EBITDA for the third quarter, reaching $1.4 billion. The company raised its 2025 potash sales volume guidance to 14 million to 14.5 million tonnes, supported by strong offshore demand, while maintaining the midpoint of its retail adjusted EBITDA guidance, reflecting stability in that segment. Nutrien achieved significant improvements in its nitrogen operations with a 94% ammonia utilization rate, up 7 percentage points from the previous year. The company also announced a strategic review of its Phosphate business and completed a controlled shutdown of its Trinidad Nitrogen operations, which were projected to contribute approximately 1% of consolidated free cash flow. Nutrien allocated $1.2 billion to dividends and share repurchases in the first nine months, a 42% increase from the prior year, and is on track to achieve its $200 million cost reduction target a year ahead of schedule. Looking ahead, Nutrien maintains a positive market outlook with expectations for record global potash shipments in 2025 and continued demand growth into 2026.

Nutrien Financial Statement Overview

Summary
Nutrien's financials show a mixed picture. Revenue growth is stabilizing, but profitability margins are under pressure. The balance sheet reflects increased leverage, yet remains stable with a strong equity base. Cash flow performance is a highlight, with significant improvement in free cash flow, indicating financial health.
Income Statement
65
Positive
Nutrien's income statement shows a mixed performance. The TTM (Trailing-Twelve-Months) revenue growth is slightly positive at 1.1%, indicating a recovery from previous declines. However, margins have compressed significantly compared to historical highs, with the net profit margin at 2.05% and EBIT margin at 6.44%. The gross profit margin remains stable at around 29.4%, suggesting some resilience in cost management. Overall, while revenue is stabilizing, profitability remains under pressure.
Balance Sheet
70
Positive
The balance sheet reflects a moderate financial position. The debt-to-equity ratio has increased to 0.61 in the TTM, indicating higher leverage, but it remains manageable. Return on equity has decreased to 2.14%, reflecting lower profitability. The equity ratio is stable, suggesting a solid asset base. While leverage has increased, the company maintains a strong equity position, providing some financial stability.
Cash Flow
75
Positive
Cash flow analysis reveals strong free cash flow growth in the TTM at 99.4%, a significant improvement. The operating cash flow to net income ratio is 0.23, indicating that cash generation is aligned with earnings. The free cash flow to net income ratio is 0.28, showing effective cash conversion. Despite past fluctuations, the recent surge in free cash flow is a positive indicator of financial health.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue25.96B25.97B29.06B37.88B27.71B20.91B
Gross Profit7.58B7.53B8.47B15.42B9.41B5.24B
EBITDA4.99B4.21B4.88B12.78B6.58B2.89B
Net Income1.36B674.00M1.26B7.66B3.15B459.00M
Balance Sheet
Total Assets53.26B51.84B52.75B54.59B49.95B47.19B
Cash, Cash Equivalents and Short-Term Investments1.39B853.00M941.00M901.00M499.00M1.45B
Total Debt13.64B12.81B12.57B11.93B10.85B11.36B
Total Liabilities28.14B27.40B27.55B28.72B26.25B24.83B
Stockholders Equity25.09B24.41B25.16B25.82B23.65B22.36B
Cash Flow
Free Cash Flow1.71B1.38B2.47B5.67B2.10B1.77B
Operating Cash Flow3.67B3.54B5.07B8.11B3.89B3.32B
Investing Cash Flow-1.76B-2.13B-2.96B-2.90B-1.81B-1.20B
Financing Cash Flow-1.52B-1.45B-2.06B-4.73B-3.00B-1.34B

Nutrien Technical Analysis

Technical Analysis Sentiment
Negative
Last Price77.62
Price Trends
50DMA
80.11
Negative
100DMA
79.96
Negative
200DMA
77.36
Positive
Market Momentum
MACD
-0.03
Positive
RSI
42.58
Neutral
STOCH
20.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NTR, the sentiment is Negative. The current price of 77.62 is below the 20-day moving average (MA) of 79.59, below the 50-day MA of 80.11, and above the 200-day MA of 77.36, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 42.58 is Neutral, neither overbought nor oversold. The STOCH value of 20.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:NTR.

Nutrien Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$642.84M4.2233.41%20.52%1196.33%
68
Neutral
$38.03B15.327.22%3.95%2.67%154.37%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
57
Neutral
$35.10M-6.16-310.19%49.17%-1068.82%
50
Neutral
$20.06M-4.72-32.75%-29.91%-89.29%
46
Neutral
C$57.94M-5.09-37.27%-36.30%10.13%
43
Neutral
C$6.13M-7.77-21.94%39.56%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:NTR
Nutrien
77.62
14.71
23.38%
TSE:KRN
Karnalyte Resources
0.11
>-0.01
-8.33%
TSE:NPK
Verde Agritech
0.98
0.33
50.77%
TSE:IFOS
Itafos
3.09
1.37
79.76%
TSE:ERTH
EarthRenew
0.18
0.14
350.00%
TSE:MGRO
MustGrow Biologics
0.65
-1.16
-64.09%

Nutrien Corporate Events

Business Operations and StrategyStock BuybackFinancial DisclosuresM&A Transactions
Nutrien Reports Strong Q3 2025 Results and Strategic Business Review
Positive
Nov 5, 2025

Nutrien Ltd. reported strong third-quarter 2025 results, with net earnings of $0.5 billion and adjusted EBITDA of $1.4 billion. The company has shown significant earnings growth through increased fertilizer sales and improved operational efficiency. Nutrien is reviewing strategic alternatives for its Phosphate business to enhance long-term value and has completed a controlled shutdown of its Trinidad Nitrogen facility due to operational challenges. Additionally, Nutrien plans to sell its stake in Profertil S.A., aiming to use the proceeds for growth investments, share repurchases, and debt reduction, aligning with its strategic focus on core assets.

The most recent analyst rating on (TSE:NTR) stock is a Hold with a C$87.00 price target. To see the full list of analyst forecasts on Nutrien stock, see the TSE:NTR Stock Forecast page.

Business Operations and StrategyFinancial DisclosuresM&A Transactions
Nutrien Reports Strong Q3 2025 Results and Strategic Business Moves
Positive
Nov 5, 2025

Nutrien Ltd. reported strong financial performance for the third quarter of 2025, with net earnings of $0.5 billion and an adjusted EBITDA of $1.4 billion. The company achieved record fertilizer sales volumes and improved reliability, contributing to increased earnings and cash returns to shareholders. Nutrien is reviewing strategic alternatives for its Phosphate business to enhance long-term value and has completed a controlled shutdown of its Trinidad Nitrogen facility due to operational challenges. The company also announced the sale of its equity interest in Profertil S.A., aligning with its capital allocation priorities.

The most recent analyst rating on (TSE:NTR) stock is a Hold with a C$87.00 price target. To see the full list of analyst forecasts on Nutrien stock, see the TSE:NTR Stock Forecast page.

Business Operations and StrategyDividends
Nutrien Declares Quarterly Dividend, Reinforcing Shareholder Value
Positive
Nov 5, 2025

Nutrien Ltd. announced a quarterly dividend of US$0.545 per share, payable on January 16, 2026, to shareholders of record as of December 31, 2025. This announcement reflects Nutrien’s ongoing commitment to providing shareholder value and highlights its robust financial position, which allows it to continue rewarding investors while maintaining its strategic focus on growth and efficiency in the agricultural sector.

The most recent analyst rating on (TSE:NTR) stock is a Hold with a C$87.00 price target. To see the full list of analyst forecasts on Nutrien stock, see the TSE:NTR Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Nutrien Initiates Shutdown of Trinidad Nitrogen Operations Amid Supply Challenges
Negative
Oct 21, 2025

Nutrien Ltd. has announced a controlled shutdown of its Trinidad Nitrogen operations due to port access restrictions and unreliable natural gas supply, which have impacted the facility’s financial performance. Despite this, Nutrien expects to meet its 2025 nitrogen sales volume targets, thanks to strong performance from its North American operations, and continues to engage with stakeholders to assess future options.

The most recent analyst rating on (TSE:NTR) stock is a Hold with a C$87.00 price target. To see the full list of analyst forecasts on Nutrien stock, see the TSE:NTR Stock Forecast page.

Business Operations and StrategyM&A Transactions
Nutrien to Divest Stake in Profertil for $600 Million
Positive
Sep 8, 2025

Nutrien Ltd. announced an agreement to sell its 50 percent equity position in the Argentine nitrogen producer Profertil S.A. to Adecoagro S.A. and Asociacion de Cooperativas Argentinas Coop Ltda for approximately $600 million. This strategic move aligns with Nutrien’s focus on core assets and geographies, with plans to allocate proceeds towards growth investments, share repurchases, and debt reduction, enhancing earnings quality and supporting long-term growth.

The most recent analyst rating on (TSE:NTR) stock is a Hold with a C$64.00 price target. To see the full list of analyst forecasts on Nutrien stock, see the TSE:NTR Stock Forecast page.

Nutrien Reports Strong Q2 2025 Earnings Amid Favorable Market
Aug 8, 2025

Nutrien Ltd., a leading global provider of crop inputs and services, operates a world-class network of production, distribution, and ag retail facilities, focusing on creating long-term value across the agricultural value chain. In its second quarter of 2025, Nutrien reported net earnings of $1.2 billion and an adjusted EBITDA of $2.5 billion, reflecting strong operational performance and favorable fertilizer market conditions. Key highlights include record Potash sales volumes, increased Nitrogen operating rates, and a significant return of $0.8 billion to shareholders through dividends and share repurchases. Nutrien has raised its full-year Potash sales volume guidance and continues to maintain capital allocation priorities. Looking forward, Nutrien remains optimistic about the fertilizer market fundamentals, driven by strong global demand and supply disruptions, and aims to achieve its 2026 performance targets while continuing to optimize operations and shareholder returns.

Nutrien’s Earnings Call: Strong Potash Sales & Positive Outlook
Aug 8, 2025

Nutrien’s recent earnings call painted a picture of robust performance, particularly in the potash and nitrogen segments, while also acknowledging challenges in the phosphate market and certain regional areas due to adverse weather conditions. The company showcased its strategic progress and effective cost management, marking a positive sentiment overall.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025